Profiling Docetaxel in Plasma and Urine Samples from a Pediatric Cancer Patient Using Ultrasound-Assisted Dispersive Liquid–Liquid Microextraction Combined with LC–MS/MS

In recent years, therapeutic drug monitoring (TDM) has been applied in docetaxel (DOC)-based anticancer therapy to precisely control various pharmacokinetic parameters, including the concentration of DOC in biofluids (e.g., plasma or urine), its clearance, and its area under the curve (AUC). The abi...

Descripción completa

Detalles Bibliográficos
Autores principales: Maliszewska, Olga, Roszkowska, Anna, Lipiński, Marcin, Treder, Natalia, Olędzka, Ilona, Kowalski, Piotr, Bączek, Tomasz, Bień, Ewa, Krawczyk, Małgorzata Anna, Plenis, Alina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143245/
https://www.ncbi.nlm.nih.gov/pubmed/37111740
http://dx.doi.org/10.3390/pharmaceutics15041255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143245/
https://www.ncbi.nlm.nih.gov/pubmed/37111740
http://dx.doi.org/10.3390/pharmaceutics15041255

Ejemplares similares